Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 300
- Registration Number
- NCT02296164
- Locations
- 🇺🇸
Investigator Site, Fairfax, Virginia, United States
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
- Conditions
- CachexiaNon-Small Cell Lung Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-07-18
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 513
- Registration Number
- NCT01395914
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
- Conditions
- CachexiaNon-Small Cell Lung Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 484
- Registration Number
- NCT01387269
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
- Conditions
- CachexiaNon-Small Cell Lung Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 495
- Registration Number
- NCT01387282
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
- Conditions
- Gastrointestinal Dysmotility
- Interventions
- Drug: Saline Solution for Injection
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 320
- Registration Number
- NCT01280344
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 117
- Registration Number
- NCT00672074
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸USC/Norris Cancer Center, Los Angeles, California, United States
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Drug: placebo
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 228
- Registration Number
- NCT00622193
- Locations
- 🇺🇸
John Hopkins University, Baltimore, Maryland, United States
🇮🇳SEAROC Cancer Center, Jaipur, Rajasthan, India
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
- First Posted Date
- 2006-09-19
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 51
- Registration Number
- NCT00378131
- Locations
- 🇺🇸
Charleston Cancer Center, Charleston, South Carolina, United States
🇺🇸Beth Israel Cancer Center, New York, New York, United States
🇺🇸Palo Verde Hematology Oncology, Ltd., Glendale, Arizona, United States
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
- First Posted Date
- 2005-12-20
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Registration Number
- NCT00267358
- Locations
- 🇺🇸
Sant Chawla, Inc., Santa Monica, California, United States
🇺🇸Hematology Oncology Consultants, Inc., Columbus, Ohio, United States
🇺🇸Advanced Medical Research Institute, Fresno, California, United States
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
- Conditions
- Cancer Cachexia
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Target Recruit Count
- 80
- Registration Number
- NCT00219817
- Locations
- 🇺🇸
California Cancer Care Center, Greenbrae, California, United States
🇺🇸Cancer Outreach Associates, Abingdon, Virginia, United States
🇺🇸Columbia University Medical Center, New York, New York, United States